1. Home
  2. SHOO vs SYRE Comparison

SHOO vs SYRE Comparison

Compare SHOO & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Steven Madden Ltd.

SHOO

Steven Madden Ltd.

HOLD

Current Price

$43.77

Market Cap

2.5B

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$33.71

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHOO
SYRE
Founded
1990
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.6B
IPO Year
1993
2016

Fundamental Metrics

Financial Performance
Metric
SHOO
SYRE
Price
$43.77
$33.71
Analyst Decision
Buy
Strong Buy
Analyst Count
8
4
Target Price
$41.00
$55.50
AVG Volume (30 Days)
940.0K
745.7K
Earning Date
11-05-2025
11-04-2025
Dividend Yield
1.93%
N/A
EPS Growth
N/A
N/A
EPS
0.78
N/A
Revenue
$2,362,727,000.00
N/A
Revenue This Year
$13.06
N/A
Revenue Next Year
$11.62
N/A
P/E Ratio
$55.85
N/A
Revenue Growth
6.41
N/A
52 Week Low
$19.05
$10.91
52 Week High
$44.99
$35.31

Technical Indicators

Market Signals
Indicator
SHOO
SYRE
Relative Strength Index (RSI) 63.66 70.06
Support Level $41.25 $33.24
Resistance Level $44.99 $35.31
Average True Range (ATR) 1.49 1.79
MACD -0.05 0.18
Stochastic Oscillator 76.59 81.89

Price Performance

Historical Comparison
SHOO
SYRE

About SHOO Steven Madden Ltd.

Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: